Li Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Li Li has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Chuntao Yan
The Central Laboratory of Kunming First People's Hospital, First People's Hospital of Kunming City & The Calmette Affiliated Hospital of Kunming Medical University, Kunming, China
2 shared publicationsJianghua Ran
Kunming Med Univ, Peoples Hosp Kunming 1, Calmette Affiliated Hosp, Clin Med Ctr Organ Transplantat Yunnan Prov,Liver, Kunming, Peoples R China
2 shared publicationsJie Jiang
Department of Hepato-Pancreato-Biliary Surgery, First People's Hospital of Kunming City & The Calmette Affiliated Hospital of Kunming Medical University, Kunming, China
2 shared publicationsLaibang Li
Kunming Med Univ, Peoples Hosp Kunming 1, Calmette Affiliated Hosp, Clin Med Ctr Organ Transplantat Yunnan Prov,Liver, Kunming, Peoples R China
2 shared publicationsShengning Zhang
Kunming Med Univ, Peoples Hosp Kunming 1, Calmette Affiliated Hosp, Clin Med Ctr Organ Transplantat Yunnan Prov,Liver, Kunming, Peoples R China
2 shared publicationsWei Liu
Department of Hepato-Pancreato-Biliary Surgery, The People's Hospital of Chuxiong Yi Autonomous Prefecture & The Fourth Affiliated Hospital of Dali University, Chuxiong, China
2 shared publications
Latest Publications
- Open Access
- 12 October 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (19) , 1066
Characteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation
Background: To establish an animal model of pre-sensitization following liver transplantation either with or without immunosuppressors. To study whether accelerated liver rejection or acute antibody-mediated rejection (AMR) occurred and study the characteristics and potential mechanism in the animal model. Methods: Lewis (LEW) rats were subjected to liver [liver graft of Brown Norway (BN) rat] transplantation 2 weeks after lymphocyte injection (lymphocytes of BN rat; pre-sensitization). At 2 weeks after transplantation, serum samples of recipients were collected for antibody analysis to identify donor-specific alloantibody (DSA) level. The recipients were treated with or without a low dose of immunosuppressor (2 mg/kg). The liver grafts of each group were analyzed by hematoxylin and eosin (HE) stain, Masson stain, CK19, C4d, and CD20 immunohistochemical (IHC) stain, CD3, CD68, and CD86 immunofluorescence and transmission electron microscope (TEM) to study the characteristics of liver rejection. Moreover, cytotoxin-associated genes, M1 macrophages conversion-related proteins, and interleukin-6 (IL-6) signaling pathway proteins were detected by western blotting. Results: High level of DSA and accelerated liver rejection occurred in the pre-sensitized rat models following liver transplant. Accelerated liver graft rejection occurred in the pre-sensitized, post liver transplant rats regardless of whether a low dose immunosuppressor had been applied. Severe injury of the interlobular bile ducts and accelerated fibrosis could be observed. Moreover, evidence of endothelial injury, such as capillary inflammation, was found in the pre-sensitized, post-transplant rats. In addition, C4d deposition and M1 macrophages recruitment were also found in this sensitized followed transplant model, indicating that complement activation might occur in this model. The levels of IL-6, JAK1, STAT3, SHP2, and ERK1-2 were increased in the pre-sensitized, post-transplant rats. Conclusions: Pre-sensitized post liver transplant rats might be potential AMR models for further study.
- 12 October 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (19) , 1066
Open AccessCharacteristics of pre-sensitization-related acute antibody-mediated rejection in a rat model of orthotopic liver transplantation
Background: To establish an animal model of pre-sensitization following liver transplantation either with or without immunosuppressors. To study whether accelerated liver rejection or acute antibody-mediated rejection (AMR) occurred and study the characteristics and potential mechanism in the animal model. Methods: Lewis (LEW) rats were subjected to liver [liver graft of Brown Norway (BN) rat] transplantation 2 weeks after lymphocyte injection (lymphocytes of BN rat; pre-sensitization). At 2 weeks after transplantation, serum samples of recipients were collected for antibody analysis to identify donor-specific alloantibody (DSA) level. The recipients were treated with or without a low dose of immunosuppressor (2 mg/kg). The liver grafts of each group were analyzed by hematoxylin and eosin (HE) stain, Masson stain, CK19, C4d, and CD20 immunohistochemical (IHC) stain, CD3, CD68, and CD86 immunofluorescence and transmission electron microscope (TEM) to study the characteristics of liver rejection. Moreover, cytotoxin-associated genes, M1 macrophages conversion-related proteins, and interleukin-6 (IL-6) signaling pathway proteins were detected by western blotting. Results: High level of DSA and accelerated liver rejection occurred in the pre-sensitized rat models following liver transplant. Accelerated liver graft rejection occurred in the pre-sensitized, post liver transplant rats regardless of whether a low dose immunosuppressor had been applied. Severe injury of the interlobular bile ducts and accelerated fibrosis could be observed. Moreover, evidence of endothelial injury, such as capillary inflammation, was found in the pre-sensitized, post-transplant rats. In addition, C4d deposition and M1 macrophages recruitment were also found in this sensitized followed transplant model, indicating that complement activation might occur in this model. The levels of IL-6, JAK1, STAT3, SHP2, and ERK1-2 were increased in the pre-sensitized, post-transplant rats. Conclusions: Pre-sensitized post liver transplant rats might be potential AMR models for further study.
- Open Access
- 1 May 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (5) , 1173-1187
Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression
Original Article Mechanism of HBV-positive liver cancer cell exosomal miR-142- 3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression Zongqiang Hu, Hui Zhang, Wei Liu, Yanfeng Yin, Jie Jiang, Chuntao Yan, Yiting Wang, Li Li
- 1 May 2022
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 11 (5) , 1173-1187
Open AccessMechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression
Original Article Mechanism of HBV-positive liver cancer cell exosomal miR-142- 3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression Zongqiang Hu, Hui Zhang, Wei Liu, Yanfeng Yin, Jie Jiang, Chuntao Yan, Yiting Wang, Li Li
- Open Access
- 1 April 2022
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 13 (2) , 754-767
Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression
Original Article Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression Zongqiang Hu, Yanfeng Yin, Jie Jiang, Chuntao Yan, Yiting Wang, Dongdong Wang, Li Li
- 1 April 2022
- Published by AME Publishing Company in Journal of Gastrointestinal Oncology
- Vol. 13 (2) , 754-767
Open AccessExosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression
Original Article Exosomal miR-142-3p secreted by hepatitis B virus (HBV)-hepatocellular carcinoma (HCC) cells promotes ferroptosis of M1-type macrophages through SLC3A2 and the mechanism of HCC progression Zongqiang Hu, Yanfeng Yin, Jie Jiang, Chuntao Yan, Yiting Wang, Dongdong Wang, Li Li
- 4 November 2019
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 16 (6) , 653-665
Study of Recellularized Human Acellular Arterial Matrix Repairs Porcine Biliary Segmental Defects
Background: With the popularity of laparoscopic cholecystectomy, common bile duct injury has been reported more frequently. There is no perfect method for repairing porcine biliary segmental defects. Methods: After the decellularization of human arterial blood vessels, the cells were cultured with GFP+ (carry green fluorescent protein) porcine bile duct epithelial cells. The growth and proliferation of porcine bile duct epithelial cells on the human acellular arterial matrix (HAAM) were observed by hematoxylin–eosin (HE) staining, electron microscopy, and immunofluorescence. Then, the recellularized human acellular arterial matrix (RHAAM) was used to repair biliary segmental defects in the pig. The feasibility of it was detected by magnetic resonance cholangiopancreatography, liver function and blood routine changes, HE staining, immunofluorescence, real-time quantitative PCR (RT-qPCR), and western blot. Results: After 4 weeks (w) of co-culture of HAAM and GFP+ porcine bile duct epithelial cells, GFP+ porcine bile duct epithelial cells grew stably, proliferated, and fused on HAAM. Bile was successfully drained into the duodenum without bile leakage or biliary obstruction. Immunofluorescence detection showed that GFP-positive bile duct cells could still be detected after GFP-containing bile duct cells were implanted into the acellular arterial matrix for 8 w. The implanted bile duct cells can successfully resist bile invasion and protect the acellular arterial matrix until the newborn bile duct is formed. Conclusion: The RHAAM can be used to repair biliary segmental defects in pigs, which provides a new idea for the clinical treatment of common bile duct injury.
- 4 November 2019
- Published by Springer Nature in Tissue Engineering and Regenerative Medicine
- Vol. 16 (6) , 653-665
Study of Recellularized Human Acellular Arterial Matrix Repairs Porcine Biliary Segmental Defects
Background: With the popularity of laparoscopic cholecystectomy, common bile duct injury has been reported more frequently. There is no perfect method for repairing porcine biliary segmental defects. Methods: After the decellularization of human arterial blood vessels, the cells were cultured with GFP+ (carry green fluorescent protein) porcine bile duct epithelial cells. The growth and proliferation of porcine bile duct epithelial cells on the human acellular arterial matrix (HAAM) were observed by hematoxylin–eosin (HE) staining, electron microscopy, and immunofluorescence. Then, the recellularized human acellular arterial matrix (RHAAM) was used to repair biliary segmental defects in the pig. The feasibility of it was detected by magnetic resonance cholangiopancreatography, liver function and blood routine changes, HE staining, immunofluorescence, real-time quantitative PCR (RT-qPCR), and western blot. Results: After 4 weeks (w) of co-culture of HAAM and GFP+ porcine bile duct epithelial cells, GFP+ porcine bile duct epithelial cells grew stably, proliferated, and fused on HAAM. Bile was successfully drained into the duodenum without bile leakage or biliary obstruction. Immunofluorescence detection showed that GFP-positive bile duct cells could still be detected after GFP-containing bile duct cells were implanted into the acellular arterial matrix for 8 w. The implanted bile duct cells can successfully resist bile invasion and protect the acellular arterial matrix until the newborn bile duct is formed. Conclusion: The RHAAM can be used to repair biliary segmental defects in pigs, which provides a new idea for the clinical treatment of common bile duct injury.
- Open Access
- 1 February 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 1003-1016
Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
Growing evidence demonstrates that long noncoding RNAs (lncRNAs) are involved in the progression of various cancers, including hepatocellular carcinoma (HCC). The role of nuclear-enriched abundant transcript 1 (NEAT1), an essential lncRNA for the formation of nuclear body paraspeckles, has not been fully explored in HCC. We aimed to determine the expression, roles and functional mechanisms of NEAT1 in the proliferation and invasion of HCC. Based on real-time polymerase chain reaction data, we suggest that NEAT1 is upregulated in HCC tissues compared with noncancerous liver tissues. The knockdown of NEAT1 altered global gene expression patterns and reduced HCC cell proliferation, invasion and migration. RNA immunoprecipitation and RNA pull-down assays confirmed that U2AF65 binds to NEAT1. Furthermore, the study indicated that NEAT1 regulated hnRNP A2 expression and that this regulation may be associated with the NEAT1–U2AF65 protein complex. Thus, the NEAT1-hnRNP A2 regulation mechanism promotes HCC pathogenesis and may provide a potential target for the prognosis and treatment of HCC.
- 1 February 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 1003-1016
Open AccessLong noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells
Growing evidence demonstrates that long noncoding RNAs (lncRNAs) are involved in the progression of various cancers, including hepatocellular carcinoma (HCC). The role of nuclear-enriched abundant transcript 1 (NEAT1), an essential lncRNA for the formation of nuclear body paraspeckles, has not been fully explored in HCC. We aimed to determine the expression, roles and functional mechanisms of NEAT1 in the proliferation and invasion of HCC. Based on real-time polymerase chain reaction data, we suggest that NEAT1 is upregulated in HCC tissues compared with noncancerous liver tissues. The knockdown of NEAT1 altered global gene expression patterns and reduced HCC cell proliferation, invasion and migration. RNA immunoprecipitation and RNA pull-down assays confirmed that U2AF65 binds to NEAT1. Furthermore, the study indicated that NEAT1 regulated hnRNP A2 expression and that this regulation may be associated with the NEAT1–U2AF65 protein complex. Thus, the NEAT1-hnRNP A2 regulation mechanism promotes HCC pathogenesis and may provide a potential target for the prognosis and treatment of HCC.
- 1 August 2015
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 14 (4) , 386-393
LXRα gene downregulation by lentiviral-based RNA interference enhances liver function after fatty liver transplantation in rats
- 1 August 2015
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 14 (4) , 386-393
LXRα gene downregulation by lentiviral-based RNA interference enhances liver function after fatty liver transplantation in rats